Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Durvalumab with bevacizumab and chemotherapy for treating advanced ovarian cancers	Bevacizumab (Avastin; R 435; RG 405; RG 435) , Chemotherapy , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736)	Ovarian cancer	Female Reproductive Cancer	2023	View \| Download
Dupilumab for eosinophilic oesophagitis in paediatric patients	Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893)	Eosinophilic oesophagitis	Gastroenterology , Immunology	2023	View \| Download
Dostarlimab with paclitaxel and carboplatin for recurrent or primary advanced endometrial cancer	Carboplatin (Paraplatin) , Dostarlimab (TSR-042; Jemperli) , Paclitaxel (Taxol; paclitaxel albumin)	Endometrial cancer	Female Reproductive Cancer	2023	View \| Download
Dostarlimab with chemotherapy and niraparib for treating advanced epithelial ovarian cancers – first line	Chemotherapy , Dostarlimab (TSR-042; Jemperli) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate)	Epithelial ovarian cancers	Female Reproductive Cancer	2023	View \| Download
Deucravacitinib for treating active psoriatic arthritis	Deucravacitinib (BMS-986165)	Psoriatic arthritis	Dermatology , Rheumatology	2023	View \| Download
Delgocitinib for treating moderate to severe chronic hand eczema after 1 previous therapy	Delgocitinib	Chronic hand eczema	Dermatology	2023	View \| Download
Degarelix acetate prior to or with radiotherapy for prostate cancer	Degarelix acetate , Radiotherapy	Prostate cancer	Male Reproductive Cancer	2023	View \| Download
Datopotamab deruxtecan for previously treated unresectable or metastatic HR+ HER2- breast cancer	Datopotamab deruxtecan (DS-1062)	Breast cancer	Breast Cancer	2023	View \| Download
Datopotamab deruxtecan for previously treated advanced non-small-cell lung cancer	Datopotamab deruxtecan (DS-1062)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Dapsone for treating COVID-19	Dapsone (PULM-001;Pulmonem)	COVID-19	Respiratory System	2023	View \| Download